Lululemon Significantly Lowers FY26 Guidance; Under Pressure from Both Product and Brand

Overview

This is a company research report by Bernstein on Lululemon (LULU.US). Following the company's significant downgrade of its FY26 performance guidance, the report raises a core question: Is the current weakness a "product issue" (which can be gradually repaired within the next year) or a deeper "brand issue" (which could drag down sales and valuations for years)? The report's conclusion is neutral: product-related headwinds are expected to last at least until FY27, and while brand equity has shown initial signs of loosening, it is judged to be "repairable rather than permanently damaged." Overall, FY27 is viewed as an adjustment year, with a true recovery possible only in FY28. Based on this, the firm lowers its target price from $170 to $145, reduces the valuation multiple from 12x to 11x FY27 EPS, and maintains a Market-Perform rating.

Core views

Performance and Guidance: FY26 guidance has been significantly revised downward. Revenue guidance was lowered from the previous +2~4% to -1% to flat, with North America expected to decline by high single digits, China to grow by approximately 20%, and the Rest of World to grow by mid-double digits. Gross margin guidance was slightly raised to 55.7%, but operating margin guidance was lowered from 17.4% to 16.1%, partly due to a year-over-year increase in marketing expenses of about 100 bps and expense deleverage from declining revenue. Diluted EPS guidance was reduced from $12.10-12.30 to $10.95-11.15 (excluding buybacks; if adjusted based on FY25 buyback levels, the midpoint is approximately $11.55). Q2 guidance is also below expectations: revenue guidance of $2.45-2.475 billion is about 5% below market expectations; gross margin is expected to drop 410 bps year-over-year to 54.5%; operating margin is around 11.6%; and EPS guidance of $1.76-1.81 is about 33% below market expectations. Q1 Actual Performance: Q1 sales grew by 2% on a constant currency basis (guidance was 1-3%), but comparable store sales declined by 2%. By region, the Americas were -4% (comparable store sales -6%), China was +23% (comparable store sales +13%), and the Rest of World was +9% (comparable store sales +1%). Trends were stronger in February-March, but weakened from late April to May due to negative reports regarding an "investigation into activewear allegedly using PFAS (permanent chemicals, which were phased out starting in 2023)." Profits were slightly below expectations, mainly dragged down by gross margin: gross margin fell 410 bps year-over-year to 54.2%, affected by rising tariffs, increased discounts (including credit card partnership programs and higher inventory provisions), and rising fixed costs. EBIT margin was 11.2% (down 730 bps year-over-year); Q1 EPS was $1.69. Product Issues: The report believes that products will remain a drag at least until FY27. New product performance has been poor, and full-price sales in the US have already declined slightly and are expected to slow further in Q2. Management expects full-price sales to barely turn positive by the end of the year—meaning that, aside from discounts, new products themselves are not yet sufficient to drive growth. Even with the arrival of the new CEO (Heidi O'Neill) and new design team in September, since the main product development cycle is about 15-16 months (shortened from the industry typical 18-24 months), these changes will have only a marginal impact on FY27, with significant changes not appearing until FY28. Brand Issues: The report has observed signs of loosening brand equity. In its annual Q4 longitudinal survey of global athletic apparel consumers (sample size ~3,600), Lululemon's rankings in dimensions directly related to product design and quality, such as "Performance" and "Fashion," have stagnated or declined, while the Chinese market has weakened across all dimensions. The firm worries that if product missteps are eroding brand equity, recovery will be slower. However, management's increase in marketing expenses as a percentage of sales from about 5.6% to 6.5% is seen by the report as a positive signal (preferable to cutting budgets), and marketing can be adjusted quickly within weeks to months. Therefore, the firm tends to believe that brand damage is not permanent and can be repaired through better marketing and (eventually) better products. Medium-Term Outlook and Valuation: The report positions FY27 as an "adjustment year," with the true turning point arriving in FY28. In addition to the product cycle, store structure adjustments or channel strategy changes (such as entering wholesale channels) require months of preparation, and often involve "clearing old inventory and closing stores" before discussing recovery. Thus, significant revenue reversal is difficult next year. The firm models low single-digit revenue growth and limited margin improvement for FY27, leaving larger growth and margin steps for FY28. Considering the risk of further downward revisions to FY27 figures, the report lowers the target valuation multiple to 11x FY27 EPS (FY27 EPS forecast lowered from $14.03 to $13.17), setting the target price at $145. However, it also believes that at current price levels, there is not much further downside room.

Analysis framework

The main thread of the report is to decompose a seemingly simple phenomenon of weakness into two causal chains: "product issues vs. brand issues," evaluating their repairability and required time respectively, thereby deriving judgments on earnings rhythm and valuation multiples. In terms of evidence organization: it first confirms the fact of "performance stall" by comparing Q1 actuals with guidance, then breaks down the structural differences in weakness by region (Americas/China/RoW). Next, it uses the split between "full-price sales vs. discounted sales" to judge growth quality—high discounts suppress both revenue quality and gross margins, while the persistent difficulty in turning full-price sales positive indicates that the problem lies in the new products themselves, not just promotions. On the brand side, the firm leverages its proprietary annual global athletic apparel consumer survey, using quantifiable changes in perception dimensions like "Performance" and "Fashion" as proxy indicators for brand equity. Combined with social media sentiment (negative comments on Weibo in China and Reddit/YouTube in the US) and the PFAS investigation event, it judges whether brand loosening is occurring. Regarding the time dimension, the firm particularly emphasizes the operational rhythm of a "15-16 month product development cycle," using it to infer when reforms by the new management team will appear in financial reports—this is the key basis for the conclusion of "adjustment year FY27, turning point FY28." Finally, in valuation, it implements the P/E multiple method (PE × forecast EPS): lowering both the EPS forecast and the multiple to reflect both earnings downgrades and medium-term uncertainty. The report also draws an analogy to Adidas's turnaround from 2023-26, suggesting a significant rebound may occur after hitting bottom, but notes that multiples will continue to reflect this uncertainty until the new management settles and the strategy becomes clear.

Methodology notes

• Valuation MethodPE/PEG valuation

  Pricing stocks by multiplying the P/E ratio by forecasted earnings per share (EPS)

  The report derives a $145 target price by multiplying 11x by the FY27 forecast EPS of $13.17. The key to this method is that both the "multiple" and "EPS" variables change: this report simultaneously lowers EPS (from $14.03 to $13.17) and the multiple (from 12x to 11x), so the target price reduction is greater than what would result from earnings downgrades alone. The multiple downgrade is used to reflect the risk of potential further downgrades in the future.

• Industry/Sector Analysis FrameworkVolume-Price Split

  Splitting sales into "full-price sales" and "discount (markdown) sales" to judge growth quality

  The same revenue has completely different implications depending on whether it comes from full-price sales or discounted clearance. The report judges whether weakness stems from the products themselves or merely from promotions by observing "when full-price sales turn positive" and the "breadth and depth of discounts." It finds that full-price sales struggle to turn positive and discounts remain high, thus pointing the finger at product strength and explaining why gross margins are under pressure.

• Competition and Strategy FrameworkMoat / competitive advantage

  Tracking the strength of "brand equity" as a corporate competitive moat

  For consumer brands, brand perception is the moat. The report uses its proprietary consumer longitudinal survey to track changes in Lululemon's rankings in dimensions like "Performance" and "Fashion" to judge whether the moat is becoming shallower. The logic is: product issues can be repaired relatively quickly, but if brand perception is damaged, recovery will be slower and more difficult, leading to more prolonged pressure on valuation.

• Competition and Strategy FrameworkProduct life cycle

  Using the length of the "product development cycle" to estimate the realization timing of new product reforms

  It takes about 15-16 months for main line products to go from initiation to launch (already shortened from the industry typical 18-24 months). The report uses this rhythm to infer: even if the new management team arrives in September, it will have only a marginal impact on FY27, with major changes not appearing until FY28—this is the hard constraint for the judgment of "FY27 as an adjustment year, FY28 as the turning point."

• Event Arbitrage and Behavioral FinanceEvent-driven analysis

  Using "turnaround" cases of comparable companies as analogies to assess bottoming-out and rebound potential

  The report references Adidas's turnaround from 2023-26, suggesting that a significant rebound (FY28-30) may occur after performance bottoms out. However, it emphasizes that until the new management settles and the strategy becomes clear, the market will continue to discount uncertainty, hence maintaining a neutral stance rather than turning bullish prematurely.

Asset mapping & comparison

Structured mapping from thesis to named assets (strengths, weaknesses, peers, risks).

• Lululemon Athletica Inc (LULU.US)

  Coverage subject of this report: FY26 guidance lowered due to weak new products, high discounts, and negative sentiment; target price lowered and neutral rating maintained

  Strengths

  Brand equity remains relatively strong but is starting to loosen; China market continues to maintain high growth (Q1 +23% cc); management is increasing marketing investment, shortening product development cycles, and undergoing leadership change, viewed as positive conditions for recovery

  Weaknesses

  Poor performance of new products, full-price sales struggling to turn positive; high breadth and depth of discounts suppressing gross margins; growth in the Americas turned negative, with declines in "Performance" and "Fashion" brand perception

  Comparison

  The report uses Adidas's turnaround from 2023-26 as a comparable reference, suggesting a significant rebound may occur after bottoming out, but currently remains in a phase of uncertainty

  Risks

  Overall slowdown in athletic apparel growth, margin pressure from tariffs and expenses, loss of market share in North America and other markets to Nike/Adidas and new entrants (such as Alo), disruption risks from high supplier concentration, negative sentiment related to PFAS investigation

Key data

• Q1 Sales Growth (Constant Currency)+2% (Comparable Store Sales -2%)Guidance was 1-3%; by region: Americas -4%, China +23%, RoW +9%
• Q1 Gross Margin54.2%Down 410 bps year-over-year, affected by tariffs, increased discounts, and rising fixed costs
• Q1 EBIT Margin11.2%Down 730 bps year-over-year
• Q1 EPS$1.69Guidance $1.63-1.68, Market Expectation $1.69
• FY26 Revenue Guidance-1% to FlatPreviously +2~4%, significantly revised down
• FY26 Operating Margin Guidance16.1%Previously 17.4%
• FY26 Diluted EPS Guidance$10.95-11.15Previously $12.10-12.30; midpoint approx. $11.55 if including buybacks
• Q2 Revenue Guidance$2.45-2.475 BillionApprox. 5% below market expectations
• Q2 EPS Guidance$1.76-1.81Approx. 33% below market expectations
• Target Price$145Lowered from previous $170
• Valuation Multiple and FY27 EPS11x × $13.17Multiple lowered from 12x; FY27 EPS lowered from $14.03 to $13.17
• Marketing Expenses as % of SalesApprox. 5.6% → 6.5%Increased this year, viewed by the firm as a positive signal
• Product Development CycleApprox. 15-16 MonthsShortened from the industry typical 18-24 months

Impact & implications

The report believes that Lululemon's weakness is no longer just a single-quarter fluctuation: product-related headwinds will last at least until FY27, and new products will struggle to drive growth independently before turning positive, while high discounts continue to suppress gross margins. Although the brand side has seen declines in "Performance" and "Fashion" perception and negative sentiment, it is judged to be repairable through increased marketing and improved products, rather than being permanent damage. The implication for earnings rhythm is that FY27 is an adjustment year with low single-digit revenue growth and limited margin improvement, with true recovery waiting until FY28. There is a risk of further downward revisions to FY27 figures (even a "one-time clearance"). Based on these judgments, the firm has lowered earnings forecasts and valuation multiples, reducing the target price to $145, but also points out that there is limited further downside at current price levels, hence maintaining a neutral Market-Perform rating.

Risks

• Overall growth in the athletic apparel industry is slowing, facing a high growth base from the pandemic period
• Operational expense pressures such as inflation, freight, and channel costs eroding margins
• Loss of market share in key markets like North America to Nike, Adidas, and new entrants
• High supplier concentration, posing risks of supply disruption
• Impact of negative sentiment related to the PFAS (permanent chemicals) investigation on foot traffic and sales

What to watch

• Adjustments in products, stores, and organizational structure by the new CEO arriving in September, and potential "one-time clearance"
• When full-price sales will turn from negative to positive (management expects barely positive by year-end)
• Subsequent changes in brand perception dimensions such as "Performance" and "Fashion"
• Discount (markdown) levels and intensity of seasonal clearance
• Whether FY27 earnings forecasts will be further revised downward
• Actual effect of increased marketing expenses on foot traffic and brand recovery